ctrl K

Myriad Genetics Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

7.20

-0.30 (-4.00%)

At close: Apr 29, 2025, 3:59 PM

7.20

0.00%

After-hours: Apr 29, 2025, 04:11 PM EDT

Myriad Genetics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Revenue	753.2M	678.4M	690.6M	557M	851.1M	851.1M	772.6M	771.4M
Cost of Revenue	236.2M	202M	197.6M	178.2M	201M	201M	177.2M	171.2M
Gross Profit	517M	476.4M	493M	378.8M	650.1M	650.1M	595.4M	600.2M
Operating Income	-257.4M	-123.7M	-48.7M	-194.8M	7.6M	7.6M	118.7M	49.4M
Interest Income	2.5M	2.6M	700K	9.2M	3.2M	3.2M	1.8M	1.2M
Pretax Income	-262.2M	-140.6M	-57.1M	-283.7M	200K	7.7M	116.9M	42.9M
Net Income	-263.3M	-112M	-27.2M	-223.7M	4.6M	4.6M	131M	21.8M
Selling & General & Admin	572.9M	514.7M	599.8M	500.7M	555.5M	555.5M	467.1M	476.4M
Research & Development	88.7M	85.4M	81.9M	80.9M	85.9M	85.9M	70.8M	74.4M
Other Expenses	112.8M	600K	139.3M	n/a	1.2M	1.2M	-400K	-2.5M
Operating Expenses	774.4M	600.1M	681.7M	653.3M	641.4M	641.4M	537.9M	550.8M
Interest Expense	2.9M	3.2M	6.6M	n/a	12M	12M	3.2M	6M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.01B	802.1M	879.3M	831.5M	842.4M	842.4M	715.1M	722M
Income Tax Expense	1.1M	-28.6M	-29.9M	59.9M	-4.4M	-4.4M	-13.9M	21.3M
Shares Outstanding (Basic)	82.8M	80.58M	77.71M	74.7M	73.5M	73.5M	69.4M	68.3M
Shares Outstanding (Diluted)	82.8M	80.6M	78M	74.78M	76M	76M	72M	68.8M
EPS (Basic)	-3.18	-1.39	-0.35	-2.99	0.06	0.06	1.89	0.32
EPS (Diluted)	-3.18	-1.39	-0.35	-2.99	0.06	0.06	1.82	0.32
EBITDA	-186.1M	-67.8M	14.1M	-123.4M	86.1M	86.1M	113.3M	96.4M
EBIT	-259.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	61.9M	55.9M	62.8M	71.4M	73M	73M	54.4M	48.3M